| ELEV Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||
Below is a table of the ELEV shares outstanding history going back to 6/25/2021:
Also see: ELEV Market Cap History ELEV YTD Return |
ELEV Shares Outstanding History — Elevation Oncology Share Count Over Time
As of 5/9/2025 Elevation Oncology has 59.22 million ELEV shares outstanding. Investors often track the ELEV shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ELEV share count trends over time, with 16 historical shares outstanding datapoints presented, dating back to 6/25/2021.
| ELEV Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||
ELEV Historical Shares Outstanding: +27.91% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||
| ELEV Stock Price Chart |
| About Elevation Oncology Inc |
| Elevation Oncology, Inc. is an oncology company. Co. is focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs. Its lead product candidate, EO-3021 is an antibody-drug conjugate (ADC) designed to target Claudin 18.2, which can selectively deliver a cytotoxic payload directly to cancer cells expressing Claudin 18.2. EO-3021 consists of a fully human immunoglobulin G1 (IgG1) mAb that targets Claudin 18.2 and is site-specifically conjugated to the monomethyl auristatin E (MMAE) payload via a cleavable linker with a drug-to-antibody ratio (DAR) of 2. We show 16 historical shares outstanding datapoints in our coverage of ELEV's shares outstanding history. Understanding the changing numbers of ELEV shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ELEV versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ELEV by allowing them to research ELEV shares outstanding history as well as any other stock in our coverage universe. |
| ELEV Current Stock Quote |
Quotes delayed 20 minutes  Free ELEV Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| ELEV Share Performance |
| Shares Outstanding Peers |
| Elevation Oncology (ELEV) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ELGX Shares Outstanding History ELOX Shares Outstanding History ELTX Shares Outstanding History ELUT Shares Outstanding History ELVN Shares Outstanding History ELYM Shares Outstanding History EMBC Shares Outstanding History EMMA Shares Outstanding History ENDP Shares Outstanding History ENOB Shares Outstanding History More Healthcare companies » |
ELEV Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
